NCL Institute Neuroscience
About NCL Institute Neuroscience
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
Merck KGaA, Darmstadt, Germany
1
Clinical Trials at NCL Institute Neuroscience
During the past decade, NCL Institute Neuroscience conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
2018-06-20
2021-11-12
Completed
485
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
2021-03-24
2025-11-27
Recruiting
736
Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)
2021-02-23
2023-09-11
Active, not recruiting
280
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NCL Institute Neuroscience
According to Clinical.Site data, the most researched conditions in "NCL Institute Neuroscience" are
"Multiple Sclerosis" (3 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "NCL Institute Neuroscience" in a lesser frequency.
Clinical Trials Intervention Types at NCL Institute Neuroscience
Most popular intervention types in "NCL Institute Neuroscience" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Mavenclad®" (2 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials), "Methylprednisolone" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NCL Institute Neuroscience
The vast majority of trials in "NCL Institute Neuroscience" are
4 trials for "All" genders.
Clinical Trials Status at NCL Institute Neuroscience
Currently, there are NaN active trials in "NCL Institute Neuroscience".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in NCL Institute Neuroscience,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NCL Institute Neuroscience, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".